Search research articles
Contact Us
Filters
Showing results (91-100 of 104) with videos related to
Page
of 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1996
Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines
D Machover, E Diaz-Rubio, A de Gramont, et al.
Neurosurgery
|
September 28, 2020
NEWTON-2 Cisternal (Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage): A Phase 2, Multicenter, Randomized, Open-Label Safety Study of Intracisternal EG-1962 in Aneurysmal Subarachnoid Hemorrhage
R Loch Macdonald, Daniel Hänggi, Nerissa U Ko, et al.
British Journal of Cancer
|
January 11, 2014
Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial
E Samalin, O Bouché, S Thézenas, et al.
Food & Function
|
March 25, 2026
The effect of anthocyanins through diet and supplementation on cognitive function in older adults: a multi-centre randomised controlled clinical trial
V do Rosario, K Chan, E Lorzadeh, et al.
Neurosurgery
|
December 3, 2020
Low-Dose Intravenous Heparin Infusion After Aneurysmal Subarachnoid Hemorrhage is Associated With Decreased Risk of Delayed Neurological Deficit and Cerebral Infarction
Matthew J Kole, Aaron P Wessell, Beatrice Ugiliweneza, et al.
Annals of Surgical Oncology
|
July 20, 2014
FOLFIRINOX for locally advanced pancreatic adenocarcinoma: results of an AGEO multicenter prospective observational cohort
L Marthey, A Sa-Cunha, J F Blanc, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 20, 2018
Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer
T Aparicio, O Bouché, E Francois, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
January 20, 2017
Commentaries on Viewpoint: A time for exercise: the exercise window
Normand G Boulé, Tasuku Terada, Monique E Francois, et al.
The Lancet. Public Health
|
July 27, 2025
Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis
Ding Ding, Binh Nguyen, Tracy Nau, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 25, 2019
Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)
A Adenis, J Bennouna, P L Etienne, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 104) with videos related to
Sort By:
Page
of 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1996
Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines
D Machover, E Diaz-Rubio, A de Gramont, et al.
Neurosurgery
|
September 28, 2020
NEWTON-2 Cisternal (Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage): A Phase 2, Multicenter, Randomized, Open-Label Safety Study of Intracisternal EG-1962 in Aneurysmal Subarachnoid Hemorrhage
R Loch Macdonald, Daniel Hänggi, Nerissa U Ko, et al.
British Journal of Cancer
|
January 11, 2014
Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial
E Samalin, O Bouché, S Thézenas, et al.
Food & Function
|
March 25, 2026
The effect of anthocyanins through diet and supplementation on cognitive function in older adults: a multi-centre randomised controlled clinical trial
V do Rosario, K Chan, E Lorzadeh, et al.
Neurosurgery
|
December 3, 2020
Low-Dose Intravenous Heparin Infusion After Aneurysmal Subarachnoid Hemorrhage is Associated With Decreased Risk of Delayed Neurological Deficit and Cerebral Infarction
Matthew J Kole, Aaron P Wessell, Beatrice Ugiliweneza, et al.
Annals of Surgical Oncology
|
July 20, 2014
FOLFIRINOX for locally advanced pancreatic adenocarcinoma: results of an AGEO multicenter prospective observational cohort
L Marthey, A Sa-Cunha, J F Blanc, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 20, 2018
Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer
T Aparicio, O Bouché, E Francois, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
January 20, 2017
Commentaries on Viewpoint: A time for exercise: the exercise window
Normand G Boulé, Tasuku Terada, Monique E Francois, et al.
The Lancet. Public Health
|
July 27, 2025
Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis
Ding Ding, Binh Nguyen, Tracy Nau, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 25, 2019
Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)
A Adenis, J Bennouna, P L Etienne, et al.
Page
of 11